Alexandria Venture Investments, LLC
CIK 1722024 · last filed 2023-10-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$82.83M
Companies
18
Total Filings
21
Lifetime Open-Market Net
$31.73M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Applied Therapeutics, Inc. (APLT) Delisted | 10%+ Owner | 778,977 | $0.10 | $80.2K | $29.25M | 3 | 2023-10-16 |
| Vigil Neuroscience, Inc. (VIGL) Delisted | 10%+ Owner | 192,973 | $8.05 | $1.55M | $0 | 1 | 2022-01-11 |
| XLO | 10%+ Owner | 166,423 | $8.31 | $1.38M | $0 | 1 | 2021-10-26 |
| Singular Genomics Systems, Inc. (OMIC) Delisted | 10%+ Owner | 2,645,985 | $20.01 | $52.95M | $0 | 1 | 2021-06-01 |
| VOR | 10%+ Owner | 282,804 | $14.36 | $4.06M | $0 | 1 | 2021-02-09 |
| ARS Pharmaceuticals, Inc. (SBTX) Delisted | 10%+ Owner | 699,412 | $5.87 | $4.11M | $0 | 1 | 2020-12-08 |
| Metacrine, Inc. (MTCR) Delisted | 10%+ Owner | 1,268,795 | $0.49 | $627.9K | $500.0K | 1 | 2020-09-18 |
| KYMR | 10%+ Owner | 467,932 | $86.20 | $40.34M | $0 | 1 | 2020-08-25 |
| RLAY | 10%+ Owner | 968,365 | $14.81 | $14.34M | $0 | 1 | 2020-07-20 |
| RNA | 10%+ Owner | 502,365 | $12.37 | $6.21M | $0 | 1 | 2020-06-16 |
| IMRA | 10%+ Owner | 293,013 | $17.02 | $4.99M | $0 | 1 | 2020-03-16 |
| Korro Bio, Inc. (FREQ) Delisted | 10%+ Owner | 956,175 | $14.98 | $14.32M | $0 | 1 | 2019-10-09 |
| Karuna Therapeutics, Inc. (KRTX) Delisted | 10%+ Owner | 214,447 | $329.83 | $70.73M | $480.0K | 1 | 2019-07-05 |
| IDYA | 10%+ Owner | 382,384 | $28.98 | $11.08M | $500.0K | 1 | 2019-05-30 |
| NXTC | 10%+ Owner | 197,993 | $2.08 | $410.8K | $0 | 1 | 2019-05-13 |
| CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted | 10%+ Owner | 149,637 | $33.99 | $5.09M | $1.00M | 1 | 2018-07-23 |
| EVLO | 10%+ Owner | 594,443 | $0.00 | $59 | $0 | 1 | 2018-05-21 |
| ASNS | 10%+ Owner | 225,680 | $0.08 | $17.6K | $0 | 1 | 2017-11-20 |
Recent Filings · Page 2 of 3
21 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-16 | RNA | Conv (C) | +502,365 | $0 | EDGAR |
| 2020-03-16 | IMRA | Conv (C) | +293,013 | $0 | EDGAR |
| 2019-10-09 | Korro Bio, Inc. (FREQ) Delisted | Conv (C) | +956,175 | $0 | EDGAR |
| 2019-07-05 | Karuna Therapeutics, Inc. (KRTX) Delisted | Mixed | +244,447 | $480.0K | EDGAR |
| 2019-05-30 | IDYA | Mixed | +432,384 | $500.0K | EDGAR |
| 2019-05-20 | Applied Therapeutics, Inc. (APLT) Delisted | Mixed | +10,171,728 | $29.25M | EDGAR |
| 2019-05-13 | NXTC | Conv (C) | +197,993 | $0 | EDGAR |
| 2018-08-01 | — | Mixed | +396,172 | $1.50M | |
| 2018-07-23 | CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted | Mixed | +216,304 | $1.00M | EDGAR |
| 2018-05-21 | EVLO | Conv (C) | +594,443 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.